Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharmistha Pal

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nucleic Acids Research|September 17, 2010
Genome-wide mapping of RNA Pol-II promoter usage in mouse tissues by ChIP-seqHao Sun, Jiejun Wu, Priyankara Wickramasinghe, et al.
Nature Genetics|February 8, 2005
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencingK N Harikrishnan, Maggie Z Chow, Emma K Baker, et al.
Molecular and Cellular Biology|April 27, 2021
RP58 Represses Transcriptional Programs Linked to Nonneuronal Cell Identity and Glioblastoma Subtypes in Developing NeuronsChaomei Xiang, Karla K Frietze, Yingtao Bi, et al.
Neuro-Oncology Advances|June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium studySabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 16, 2022
Modulation of Radiation Biomarkers in a Randomized Phase II Study of <sup>131</sup>I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory NeuroblastomaKevin Campbell, Susan Groshen, Angela C Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)Kristina A Cole, Sharmistha Pal, Rachel A Kudgus, et al.
Neuro-Oncology|July 19, 2015
Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniquesLuke Macyszyn, Hamed Akbari, Jared M Pisapia, et al.
Acta Neuropathologica Communications|December 10, 2019
Immune landscapes associated with different glioblastoma molecular subtypesMaria Martinez-Lage, Timothy M Lynch, Yingtao Bi, et al.
Molecular Cancer Therapeutics|February 4, 2021
Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer NanoparticlesIsidora Tošić, Lisa N Heppler, Susana P Egusquiaguirre, et al.
Blood Advances|September 12, 2025
Induction of moderate DNA damage enhances megakaryopoiesis and platelet productionVirginia Camacho, Roelof H Bekendam, Andrew P Stone, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|September 17, 2010
Genome-wide mapping of RNA Pol-II promoter usage in mouse tissues by ChIP-seqHao Sun, Jiejun Wu, Priyankara Wickramasinghe, et al.
Nature Genetics|February 8, 2005
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencingK N Harikrishnan, Maggie Z Chow, Emma K Baker, et al.
Molecular and Cellular Biology|April 27, 2021
RP58 Represses Transcriptional Programs Linked to Nonneuronal Cell Identity and Glioblastoma Subtypes in Developing NeuronsChaomei Xiang, Karla K Frietze, Yingtao Bi, et al.
Neuro-Oncology Advances|June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium studySabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 16, 2022
Modulation of Radiation Biomarkers in a Randomized Phase II Study of <sup>131</sup>I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory NeuroblastomaKevin Campbell, Susan Groshen, Angela C Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)Kristina A Cole, Sharmistha Pal, Rachel A Kudgus, et al.
Neuro-Oncology|July 19, 2015
Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniquesLuke Macyszyn, Hamed Akbari, Jared M Pisapia, et al.
Acta Neuropathologica Communications|December 10, 2019
Immune landscapes associated with different glioblastoma molecular subtypesMaria Martinez-Lage, Timothy M Lynch, Yingtao Bi, et al.
Molecular Cancer Therapeutics|February 4, 2021
Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer NanoparticlesIsidora Tošić, Lisa N Heppler, Susana P Egusquiaguirre, et al.
Blood Advances|September 12, 2025
Induction of moderate DNA damage enhances megakaryopoiesis and platelet productionVirginia Camacho, Roelof H Bekendam, Andrew P Stone, et al.
Pageof 4